Blood, ISSN 0006-4971, 07/2018, Volume 132, Issue 3, pp. 239 - 240
In this issue of Blood, Hrusak et al show the superiority of acute lymphoblastic leukemia (ALL) type therapy in most cases of ambiguous lineage acute...
PHENOTYPE | ACUTE-LEUKEMIA | CLASSIFICATION | HEMATOLOGY
PHENOTYPE | ACUTE-LEUKEMIA | CLASSIFICATION | HEMATOLOGY
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2010, Volume 93, Issue 7, pp. 2413.e15 - 2413.e19
Objective To report the first case of restoration of ovarian activity and live birth after cryopreserved ovarian tissue autograft in a patient without cancer...
Internal Medicine | Obstetrics and Gynecology | autotransplantation | Ovarian tissue | live birth | cryopreservation | sickle cell disease | Live birth | Sickle cell disease | Cryopreservation | Autotransplantation | CYCLOPHOSPHAMIDE | RESTORATION | FAILURE | CHEMOTHERAPY | PREGNANCY | FERTILITY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | OUTCOMES | XENOGRAFTS | Humans | Live Birth | Transplantation, Autologous | Primary Ovarian Insufficiency - rehabilitation | Bone Marrow Transplantation - methods | Primary Ovarian Insufficiency - therapy | Bone Marrow Transplantation - rehabilitation | Pregnancy | Anemia, Sickle Cell - therapy | Ovary - surgery | Anemia, Sickle Cell - rehabilitation | Pregnancy Complications, Hematologic - therapy | Bone Marrow Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Ovary - transplantation | Primary Ovarian Insufficiency - etiology | Infant, Newborn | Pregnancy Complications, Hematologic - rehabilitation | Transplantation, Homologous - adverse effects | Life Sciences | Immunology
Internal Medicine | Obstetrics and Gynecology | autotransplantation | Ovarian tissue | live birth | cryopreservation | sickle cell disease | Live birth | Sickle cell disease | Cryopreservation | Autotransplantation | CYCLOPHOSPHAMIDE | RESTORATION | FAILURE | CHEMOTHERAPY | PREGNANCY | FERTILITY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | OUTCOMES | XENOGRAFTS | Humans | Live Birth | Transplantation, Autologous | Primary Ovarian Insufficiency - rehabilitation | Bone Marrow Transplantation - methods | Primary Ovarian Insufficiency - therapy | Bone Marrow Transplantation - rehabilitation | Pregnancy | Anemia, Sickle Cell - therapy | Ovary - surgery | Anemia, Sickle Cell - rehabilitation | Pregnancy Complications, Hematologic - therapy | Bone Marrow Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Ovary - transplantation | Primary Ovarian Insufficiency - etiology | Infant, Newborn | Pregnancy Complications, Hematologic - rehabilitation | Transplantation, Homologous - adverse effects | Life Sciences | Immunology
Journal Article
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, p. 1884
Dehydrated hereditary stomatocytosis is a genetic condition with defective red blood cell membrane properties that causes an imbalance in intracellular cation...
STOMATIN | PSEUDOHYPERKALEMIA | PROTEIN | ERYTHROCYTES | XEROCYTOSIS | MULTIDISCIPLINARY SCIENCES | DISEASE | MOUSE | DISORDERS | CELL | LOCUS | Recombinant Proteins - metabolism | Amino Acid Sequence | Humans | Middle Aged | Ion Channels - genetics | Molecular Sequence Data | Male | Mutation - genetics | Anemia, Hemolytic, Congenital - genetics | Young Adult | Biomechanical Phenomena | Hydrops Fetalis - genetics | Ion Channel Gating - genetics | Ion Channels - metabolism | DNA Mutational Analysis | Pedigree | Adolescent | Hydrophobic and Hydrophilic Interactions | Adult | Female | Aged | Kinetics | Child | Ion Channels - chemistry | Life Sciences | Human health and pathology | Genetics | Hematology | Human genetics
STOMATIN | PSEUDOHYPERKALEMIA | PROTEIN | ERYTHROCYTES | XEROCYTOSIS | MULTIDISCIPLINARY SCIENCES | DISEASE | MOUSE | DISORDERS | CELL | LOCUS | Recombinant Proteins - metabolism | Amino Acid Sequence | Humans | Middle Aged | Ion Channels - genetics | Molecular Sequence Data | Male | Mutation - genetics | Anemia, Hemolytic, Congenital - genetics | Young Adult | Biomechanical Phenomena | Hydrops Fetalis - genetics | Ion Channel Gating - genetics | Ion Channels - metabolism | DNA Mutational Analysis | Pedigree | Adolescent | Hydrophobic and Hydrophilic Interactions | Adult | Female | Aged | Kinetics | Child | Ion Channels - chemistry | Life Sciences | Human health and pathology | Genetics | Hematology | Human genetics
Journal Article
Blood, ISSN 0006-4971, 03/2017, Volume 129, Issue 10, pp. 1380 - 1388
Anti-programmed cell death protein 1 (PD-1) monoclonal antibodies are being increasingly tested in patients with advanced lymphoma. Following treatment, many...
LETHALITY | PROGRAMMED DEATH-1 | REFRACTORY HODGKINS LYMPHOMA | UNRELATED DONORS | EUROPEAN GROUP | HEMATOLOGY | VERSUS-HOST-DISEASE | T-CELLS | WORKING PARTY | MARROW TRANSPLANTATION | BLOOD | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Neoplasm Recurrence, Local - therapy | Kaplan-Meier Estimate | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Neoplasm Recurrence, Local - mortality | Lymphoma - mortality | Young Adult | Disease-Free Survival | Allografts | Lymphoma - therapy | Statistics, Nonparametric | Adult | Female | Aged | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer | Transplantation
LETHALITY | PROGRAMMED DEATH-1 | REFRACTORY HODGKINS LYMPHOMA | UNRELATED DONORS | EUROPEAN GROUP | HEMATOLOGY | VERSUS-HOST-DISEASE | T-CELLS | WORKING PARTY | MARROW TRANSPLANTATION | BLOOD | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Neoplasm Recurrence, Local - therapy | Kaplan-Meier Estimate | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Neoplasm Recurrence, Local - mortality | Lymphoma - mortality | Young Adult | Disease-Free Survival | Allografts | Lymphoma - therapy | Statistics, Nonparametric | Adult | Female | Aged | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Index Medicus | Abridged Index Medicus | Life Sciences | Cancer | Transplantation
Journal Article
Blood, ISSN 0006-4971, 2016, Volume 127, Issue 25, pp. 3154 - 3164
Since their discovery in patients with autosomal dominant (AD) chronic mucocutaneous candidiasis (CMC) in 2011, heterozygous STAT1 gain-of-function (GOF)...
HYPER-IGE SYNDROME | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | FUNCTION SIGNAL TRANSDUCER | AUTOSOMAL-DOMINANT GAIN | IL-17 IMMUNITY | EX-VIVO | HEMATOLOGY | CHRONIC MUCOCUTANEOUS CANDIDIASIS | HOMOZYGOUS CARD9 MUTATION | T-CELLS | INBORN-ERRORS | Genetic Predisposition to Disease | Genetic Association Studies | Candidiasis, Chronic Mucocutaneous - genetics | Humans | Middle Aged | Child, Preschool | Infant | Male | STAT1 Transcription Factor - genetics | Young Adult | Phenotype | Adolescent | Adult | Female | Heterozygote | Aged | Mutation | Child | Cohort Studies | 100 | Clinical Trials and Observations
HYPER-IGE SYNDROME | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | FUNCTION SIGNAL TRANSDUCER | AUTOSOMAL-DOMINANT GAIN | IL-17 IMMUNITY | EX-VIVO | HEMATOLOGY | CHRONIC MUCOCUTANEOUS CANDIDIASIS | HOMOZYGOUS CARD9 MUTATION | T-CELLS | INBORN-ERRORS | Genetic Predisposition to Disease | Genetic Association Studies | Candidiasis, Chronic Mucocutaneous - genetics | Humans | Middle Aged | Child, Preschool | Infant | Male | STAT1 Transcription Factor - genetics | Young Adult | Phenotype | Adolescent | Adult | Female | Heterozygote | Aged | Mutation | Child | Cohort Studies | 100 | Clinical Trials and Observations
Journal Article
International Journal of Molecular Medicine, ISSN 1107-3756, 03/2017, Volume 39, Issue 3, pp. 622 - 628
Williams-Beuren syndrome (WBS, no. OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome 7q11.23 and characterized by...
RFC2 | 7q11.23 | DNA damage | Williams-Beuren syndrome | Predisposition | BAZ1B | Non-Hodgkin's lymphoma | Cancer | GTF2I | Williams syndrome | MEDICINE, RESEARCH & EXPERIMENTAL | predisposition | REGION | non-Hodgkin's lymphoma | NON-HODGKIN-LYMPHOMA | cancer | TFII-I | Cell Cycle - genetics | Cell Line | Hydroxyurea - pharmacology | RNA, Small Interfering - genetics | DNA Repair - drug effects | Genetic Predisposition to Disease | Williams Syndrome - genetics | Humans | Gene Silencing | Etoposide - pharmacology | Case-Control Studies | Gene Knockdown Techniques | Dose-Response Relationship, Drug | Williams Syndrome - metabolism | Fibroblasts | Cell Proliferation - drug effects | DNA Damage | Histones - metabolism | Cell Cycle - drug effects
RFC2 | 7q11.23 | DNA damage | Williams-Beuren syndrome | Predisposition | BAZ1B | Non-Hodgkin's lymphoma | Cancer | GTF2I | Williams syndrome | MEDICINE, RESEARCH & EXPERIMENTAL | predisposition | REGION | non-Hodgkin's lymphoma | NON-HODGKIN-LYMPHOMA | cancer | TFII-I | Cell Cycle - genetics | Cell Line | Hydroxyurea - pharmacology | RNA, Small Interfering - genetics | DNA Repair - drug effects | Genetic Predisposition to Disease | Williams Syndrome - genetics | Humans | Gene Silencing | Etoposide - pharmacology | Case-Control Studies | Gene Knockdown Techniques | Dose-Response Relationship, Drug | Williams Syndrome - metabolism | Fibroblasts | Cell Proliferation - drug effects | DNA Damage | Histones - metabolism | Cell Cycle - drug effects
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 3/2008, Volume 46, Issue 5, pp. 696 - 702
Background. Chronic disseminated candidiasis (CDC) is typically observed during neutrophil recovery in patients with acute leukemia and requires protracted...
Antifungals | Candidiasis | Corticosteroids | Liver | Leukemia | Articles and Commentaries | Neutrophils | Biopsies | Fungal infections | Symptoms | Fever | HEPATIC CANDIDIASIS | INFECTIOUS DISEASES | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | AMPHOTERICIN-B | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ACUTE-LEUKEMIA | CANCER-PATIENTS | IMMUNOCOMPROMISED PATIENTS | RECONSTITUTION INFLAMMATORY SYNDROME | SYSTEMIC CANDIDIASIS | HEPATOSPLENIC CANDIDIASIS | Fever - microbiology | Humans | Middle Aged | Child, Preschool | Male | Adrenal Cortex Hormones - therapeutic use | Antifungal Agents - therapeutic use | Immune Reconstitution Inflammatory Syndrome - physiopathology | Time Factors | Candidiasis - drug therapy | Leukemia - complications | Adult | Female | Retrospective Studies | C-Reactive Protein - analysis | Spleen - pathology | Child | Length of Stay | Immune Reconstitution Inflammatory Syndrome - microbiology | Liver Abscess - pathology | Candidiasis - physiopathology | Abdominal Pain - microbiology | Immune Reconstitution Inflammatory Syndrome - pathology | Adrenal Cortex Hormones - adverse effects | Chemotherapy, Adjuvant - methods | Fibrinogen - analysis | Adolescent | Immune Reconstitution Inflammatory Syndrome - drug therapy | Aged | Adrenal Cortex Hormones - administration & dosage | Dosage and administration | Drug therapy | Immune Reconstitution Inflammatory Syndrome | C-Reactive Protein | Adrenal Cortex Hormones | Abdominal Pain | Life Sciences | Immunology | Fibrinogen | Antifungal Agents | Chemotherapy, Adjuvant | Spleen | Liver Abscess
Antifungals | Candidiasis | Corticosteroids | Liver | Leukemia | Articles and Commentaries | Neutrophils | Biopsies | Fungal infections | Symptoms | Fever | HEPATIC CANDIDIASIS | INFECTIOUS DISEASES | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | AMPHOTERICIN-B | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ACUTE-LEUKEMIA | CANCER-PATIENTS | IMMUNOCOMPROMISED PATIENTS | RECONSTITUTION INFLAMMATORY SYNDROME | SYSTEMIC CANDIDIASIS | HEPATOSPLENIC CANDIDIASIS | Fever - microbiology | Humans | Middle Aged | Child, Preschool | Male | Adrenal Cortex Hormones - therapeutic use | Antifungal Agents - therapeutic use | Immune Reconstitution Inflammatory Syndrome - physiopathology | Time Factors | Candidiasis - drug therapy | Leukemia - complications | Adult | Female | Retrospective Studies | C-Reactive Protein - analysis | Spleen - pathology | Child | Length of Stay | Immune Reconstitution Inflammatory Syndrome - microbiology | Liver Abscess - pathology | Candidiasis - physiopathology | Abdominal Pain - microbiology | Immune Reconstitution Inflammatory Syndrome - pathology | Adrenal Cortex Hormones - adverse effects | Chemotherapy, Adjuvant - methods | Fibrinogen - analysis | Adolescent | Immune Reconstitution Inflammatory Syndrome - drug therapy | Aged | Adrenal Cortex Hormones - administration & dosage | Dosage and administration | Drug therapy | Immune Reconstitution Inflammatory Syndrome | C-Reactive Protein | Adrenal Cortex Hormones | Abdominal Pain | Life Sciences | Immunology | Fibrinogen | Antifungal Agents | Chemotherapy, Adjuvant | Spleen | Liver Abscess
Journal Article
Blood, ISSN 0006-4971, 10/2010, Volume 116, Issue 17, pp. 3249 - 3257
X-linked lymphoproliferative disease (XLP) is a condition associated with mutations in the signaling lymphocytic activation molecule (SLAM)-associated protein...
NATURAL-KILLER-CELLS | SAP | DENDRITIC CELLS | FATAL INFECTIOUS-MONONUCLEOSIS | HUMORAL IMMUNITY | RECEPTOR | LYMPHOCYTIC ACTIVATION MOLECULE | HEMATOLOGY | EXPRESSION | GENE-PRODUCT | CUTTING EDGE | Antigens, CD - immunology | Epstein-Barr Virus Infections - immunology | Humans | Cells, Cultured | Herpesvirus 4, Human - immunology | Lymphoproliferative Disorders - complications | Lymphoproliferative Disorders - immunology | Signaling Lymphocytic Activation Molecule Family | Antigen-Presenting Cells - immunology | Receptors, Cell Surface - immunology | B-Lymphocytes - immunology | Signaling Lymphocytic Activation Molecule Family Member 1 | Epstein-Barr Virus Infections - complications | Fibroblasts - immunology | T-Lymphocytes - immunology | CD8-Positive T-Lymphocytes - immunology | Life Sciences | Immunology
NATURAL-KILLER-CELLS | SAP | DENDRITIC CELLS | FATAL INFECTIOUS-MONONUCLEOSIS | HUMORAL IMMUNITY | RECEPTOR | LYMPHOCYTIC ACTIVATION MOLECULE | HEMATOLOGY | EXPRESSION | GENE-PRODUCT | CUTTING EDGE | Antigens, CD - immunology | Epstein-Barr Virus Infections - immunology | Humans | Cells, Cultured | Herpesvirus 4, Human - immunology | Lymphoproliferative Disorders - complications | Lymphoproliferative Disorders - immunology | Signaling Lymphocytic Activation Molecule Family | Antigen-Presenting Cells - immunology | Receptors, Cell Surface - immunology | B-Lymphocytes - immunology | Signaling Lymphocytic Activation Molecule Family Member 1 | Epstein-Barr Virus Infections - complications | Fibroblasts - immunology | T-Lymphocytes - immunology | CD8-Positive T-Lymphocytes - immunology | Life Sciences | Immunology
Journal Article
Acta Dermato-Venereologica, ISSN 0001-5555, 11/2016, Volume 96, Issue 7, pp. 991 - 992
HYPER-IGE SYNDROME | DEDICATOR | DEFICIENCY | CYTOKINESIS 8 DOCK8 | DERMATOLOGY | Diagnosis, Differential | Guanine Nucleotide Exchange Factors - genetics | Job Syndrome - genetics | Job Syndrome - diagnosis | Job Syndrome - therapy | Humans | Hematopoietic Stem Cell Transplantation | Male | Mutation - genetics | Child | Syndrome
Journal Article
Blood, ISSN 0006-4971, 03/2017, Volume 129, Issue 9, pp. 1227 - 1230
LEUKEMIA | HEMATOLOGY | FOCUS | TRANSPLANTATION | Age Factors | Leukemia, Myeloid, Acute - pathology | Humans | Middle Aged | Dendritic Cells - pathology | Hematopoietic Stem Cell Transplantation | Male | Treatment Outcome | Remission Induction | Cord Blood Stem Cell Transplantation | Young Adult | Disease-Free Survival | Allografts | Adult | Female | Aged | Retrospective Studies | Transplantation Conditioning - methods | France | Leukemia, Myeloid, Acute - therapy
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 06/2018, Volume 197, Issue 11, pp. e22 - e23
The patient's medical history included intrauterine growth restriction, severe growth failure (-4 SD), lymphocytic enteropathy with total villous atrophy,...
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Tomography | Family medical history | Mutation | Autoimmune diseases | Biopsy | Lung diseases | Life Sciences | Human health and pathology | Infectious diseases
RESPIRATORY SYSTEM | CRITICAL CARE MEDICINE | Tomography | Family medical history | Mutation | Autoimmune diseases | Biopsy | Lung diseases | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 02/2018, Volume 103, Issue 3, pp. E103 - E103
Journal Article
PLOS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, pp. e108848 - e108848
Background: There are several reports demonstrating the role of CD8 T cells against Leishmania species. Therefore peptide vaccine might represent an effective...
INTRADERMAL CHALLENGE | IMMUNITY IN-VIVO | PROTECTIVE IMMUNITY | IFN-GAMMA PRODUCTION | BETA-2-MICROGLOBULIN-DEFICIENT MICE | HUMAN CUTANEOUS LEISHMANIASIS | DNA VACCINE | MULTIDISCIPLINARY SCIENCES | MUCOSAL LEISHMANIASIS | TELOMERASE REVERSE-TRANSCRIPTASE | CD8(+) T-CELLS | Leishmaniasis - immunology | HLA-A2 Antigen - genetics | Leishmania major - immunology | Leishmaniasis - prevention & control | Animals | Leishmaniasis Vaccines - immunology | Mice, Transgenic | Mice | Epitopes, T-Lymphocyte - immunology | CD8-Positive T-Lymphocytes - immunology | Infection | Ubiquitin | Histocompatibility antigens | Peptides | HLA histocompatibility antigens | Liquefied petroleum gas | Genetic engineering | Vaccines | T cells | Health aspects | Antigenic determinants | Cytolytic activity | Animal models | Toxicity | CD8 antigen | Vaccination | Cytotoxicity | Lymphocytes T | Histocompatibility antigen H-2 | Infections | Parasites | Proteins | Immunology | Lymphocytes | Parasitic diseases | Coding | Splenocytes | Drb1 protein | Deoxyribonucleic acid--DNA | Enzyme-linked immunosorbent assay | Polytopes | Antigen presentation | Evaluation | Antigens | Transgenic mice | Priming | Epitopes | Chromium radioisotopes | Chemotherapy | Major histocompatibility complex | Immunogenicity | γ-Interferon | Chromium | Histocompatibility antigen HLA | Index Medicus | Deoxyribonucleic acid | DNA
INTRADERMAL CHALLENGE | IMMUNITY IN-VIVO | PROTECTIVE IMMUNITY | IFN-GAMMA PRODUCTION | BETA-2-MICROGLOBULIN-DEFICIENT MICE | HUMAN CUTANEOUS LEISHMANIASIS | DNA VACCINE | MULTIDISCIPLINARY SCIENCES | MUCOSAL LEISHMANIASIS | TELOMERASE REVERSE-TRANSCRIPTASE | CD8(+) T-CELLS | Leishmaniasis - immunology | HLA-A2 Antigen - genetics | Leishmania major - immunology | Leishmaniasis - prevention & control | Animals | Leishmaniasis Vaccines - immunology | Mice, Transgenic | Mice | Epitopes, T-Lymphocyte - immunology | CD8-Positive T-Lymphocytes - immunology | Infection | Ubiquitin | Histocompatibility antigens | Peptides | HLA histocompatibility antigens | Liquefied petroleum gas | Genetic engineering | Vaccines | T cells | Health aspects | Antigenic determinants | Cytolytic activity | Animal models | Toxicity | CD8 antigen | Vaccination | Cytotoxicity | Lymphocytes T | Histocompatibility antigen H-2 | Infections | Parasites | Proteins | Immunology | Lymphocytes | Parasitic diseases | Coding | Splenocytes | Drb1 protein | Deoxyribonucleic acid--DNA | Enzyme-linked immunosorbent assay | Polytopes | Antigen presentation | Evaluation | Antigens | Transgenic mice | Priming | Epitopes | Chromium radioisotopes | Chemotherapy | Major histocompatibility complex | Immunogenicity | γ-Interferon | Chromium | Histocompatibility antigen HLA | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 05/2017, Volume 52, Issue 5, pp. 678 - 682
Allogeneic hematopoietic stem cell transplantation (SCT) contributes to improved outcome in childhood acute leukemia (AL). However, therapeutic options are...
WORKING-PARTY | EBMT | DONOR LEUKOCYTE INFUSIONS | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | TRANSPLANTATION | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | MALIGNANCIES | RELAPSED ACUTE | BLINATUMOMAB | HEMATOLOGY | REMISSION | Acute Disease | Leukemia, Biphenotypic, Acute - therapy | Humans | Leukemia - therapy | Palliative Care | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Survival Rate | Treatment Outcome | Hematopoietic Stem Cell Transplantation - mortality | Disease Progression | Transplantation, Homologous | Leukemia, Myeloid, Acute - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Treatment Failure | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Lymphocyte Transfusion | Child | Leukemia, Biphenotypic, Acute - mortality | Leukemia, Myeloid, Acute - therapy | Leukemia - mortality | Care and treatment | Chemotherapy | Usage | Lymphocytes | Acute leukemia | Transplantation | Research | Hematopoietic stem cells | Cancer
WORKING-PARTY | EBMT | DONOR LEUKOCYTE INFUSIONS | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | TRANSPLANTATION | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | MALIGNANCIES | RELAPSED ACUTE | BLINATUMOMAB | HEMATOLOGY | REMISSION | Acute Disease | Leukemia, Biphenotypic, Acute - therapy | Humans | Leukemia - therapy | Palliative Care | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Survival Rate | Treatment Outcome | Hematopoietic Stem Cell Transplantation - mortality | Disease Progression | Transplantation, Homologous | Leukemia, Myeloid, Acute - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Treatment Failure | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Lymphocyte Transfusion | Child | Leukemia, Biphenotypic, Acute - mortality | Leukemia, Myeloid, Acute - therapy | Leukemia - mortality | Care and treatment | Chemotherapy | Usage | Lymphocytes | Acute leukemia | Transplantation | Research | Hematopoietic stem cells | Cancer
Journal Article